Hepatitis C - pegylated interferons, ribavirin and alfa interferon

Interferon alfa and ribavirin for the treatment of chronic hepatitis C - part review of exisiting guidance no.14

Summary

Guidance currently being reviewed: See review

This guidance replaces Hepatitis C - alpha interferon and ribavirin (TA14). This guidance is extended by Hepatitis C - peginterferon alfa and ribavirin(TA106)

Guidance documents

• Guidance PDF format
• Quick reference guide PDF format
• Understanding NICE guidance PDF format
• TA75 Defnyddio interferon alfa, peginterferon alfa a ribavirin i drin hepatitis C cronig: deall canllawiau NICE

Implementing this guidance

• None available

Other information

• Background information